Autoinjector with removable cap
Latest AMGEN INC. Patents:
- Methods of treating heart failure by administering omecamtiv mecarbil
- Methods for harvesting mammalian cell cultures
- Drug delivery devices and associated heating and/or cooling devices
- COMPOSITIONS AND METHODS FOR ENHANCING GENE SILENCING ACTIVITY OF OLIGONUCLEOTIDE COMPOUNDS
- DCAF4L2-SPECIFIC T-CELL RECEPTORS
The dashed lines showing portions of the autoinjector drug delivery device are included for the purpose of illustrating environment and form no part of the claimed design.
Claims
The ornamental design for an autoinjector with removable cap, as shown and described.
D321472 | November 12, 1991 | Evans |
D443641 | June 12, 2001 | Mader |
D622374 | August 24, 2010 | Julian |
D629509 | December 21, 2010 | Julian |
D697205 | January 7, 2014 | Schneider |
D721802 | January 27, 2015 | Ohashi |
D728782 | May 5, 2015 | Dubuc |
D757255 | May 24, 2016 | Wohlfahrt |
D773648 | December 6, 2016 | Wohlfahrt |
D774641 | December 20, 2016 | Miggels |
D780909 | March 7, 2017 | Burkett |
20140371684 | December 18, 2014 | Holmqvist |
20160263325 | September 15, 2016 | Huthmacher |
Type: Grant
Filed: Apr 20, 2016
Date of Patent: Mar 27, 2018
Assignee: AMGEN INC. (Thousand Oaks, CA)
Inventors: Margaux Frances Boyaval (Newbury Park, CA), Sigrid Moeslinger (New York, NY), Masamichi Udagawa (New York, NY)
Primary Examiner: David Muller
Assistant Examiner: Nathan Johnston
Application Number: 29/561,893